Home Home Home Inbox Home Search

Event

Effectiveness of Acumapimod Oral P38 Inhibitor in the Treatment of Acute Severe Exacerbations of COPD: Results of the AETHER Phase II Trial

Location: 32A
Session Type: Late Breaking Mini Symposium
Monday
May
21
9:45 AM
10:00 AM

Speaker(s)/Author(s)

Alastair MacKinnon

MB,BS
Mereo BioPharma Group plc

Jackie M. Parkin

MB,BS
Mereo BioPharma Group plc

Jadwiga A. Wedzicha

MD, PhD
Imperial College London;National Heart and Lung Institute;National Heart and Lung Institute, Imperial College London

View Abstract

Effectiveness of Acumapimod Oral P38 Inhibitor in the Treatment of Acute Severe Exacerbations of COPD: Results of the AETHER Phase II Trial

Parent Sessions

  • B14 - LATE BREAKING CLINICAL TRIALS AND FIRST REPORTS IN ASTHMA AND COPD...
    05-21-2018 9:15 AM - 11:15 AM
    • Home Home Home Inbox Home Search